R
U.S. President Donald Trump recently signed an executive order to expedite reviews and increase funding for psychedelic treatments like ibogaine, aimed at addressing severe depression and PTSD, while acknowledging the potential risks and ongoing clinical research surrounding these substances. #PsychedelicResearch #MentalHealth #DrugPolicy
Psychedelic therapies cited by Trump: What you need to know
